Joseph Sassine, MD
Infectious Disease Physician- Accepting New Patients
- Member of OU Health Physicians
- Position: Infectious Disease Physician
- Primary Specialty: Infectious Diseases
- Languages Spoken: Arabic, French, English
- Gender: Male
About Joseph Sassine
Joseph Sassine, M.D. is an infectious diseases physician with OU Health Physicians in Oklahoma City. He is an assistant professor of medicine in the section of infectious diseases in the department of Internal Medicine at the OU College of Medicine.
Dr. Sassine earned his medical degree from the Lebanese American University School of Medicine in Lebanon. He completed a residency in internal medicine at the Icahn School of Medicine at Mount Sinai, St. Luke’s-Roosevelt Hospital Center in New York, NY. Following residency, he completed a fellowship in infectious diseases with a track focused on the immunocompromised at the University of Texas Health Science Center and MD Anderson Cancer Center in Houston, TX.
Dr. Sassine is board certified in Internal Medicine and Infectious Diseases. He is a member of the American College of Physicians, the Infectious Diseases Society of America, the American Society of Transplantation and the American Society of Transplantation and Cellular Therapy.
He specializes in diagnosing and treating infections in immunocompromised hosts, including transplant recipients and patients with cancer. His research interests include infections in patients with hematological malignancies, including hematopoietic cell transplantation and CAR-T cell recipients.
- Medical School
-
Doctor of Medicine
Lebanese American University School of Medicine
Byblos, Lebanon
- Residency
-
Internal Medicine
Icahn School of Medicine at Mount Sinai, St. Luke's-Roosevelt Hospital Center
New York, NY
- Fellowship
-
Infectious Diseases
University of Texas Health Science Center, MD Anderson Cancer Center
Houston, TX
- Board Certification
- Infectious Diseases
- Internal Medicine
- Infections in patients with hematological malignancies
- Infections in patients with hematopoietic cell transplantation and CAR-T cell recipients